| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/30/2013 | CN101933922B Amino acid composition containing new antioxidant |
| 01/30/2013 | CN101912517B Spray and gauze & ointment for preventing and curing bedsore and eczema |
| 01/30/2013 | CN101912447B Rhizoma corydalis total alkaloids self-emulsifying drug delivery system and preparation method and application thereof |
| 01/30/2013 | CN101897732B Chinese medicinal effervescence medicament and preparation method thereof |
| 01/30/2013 | CN101869302B Micro-emulsion calcium preparation and preparation method as well as application thereof |
| 01/30/2013 | CN101856336B Mecobalamin sustained-release tablet and preparation method thereof |
| 01/30/2013 | CN101856328B Ketoconazole foaming agent and preparation method thereof |
| 01/30/2013 | CN101849913B Method for preparing veterinary florfenicol lung targeting gelatin microsphere |
| 01/30/2013 | CN101849907B Nanoemulsion of N-[4-(2,4 dimethoxy phenyl)-5-oxygroup-4,5-dihydro-[1,2] disulfide group-[4,3-b]-6-pyrryl]-3,5-di-trifluoromethyl benzamide and preparation method thereof |
| 01/30/2013 | CN101842085B Orally disintegrated dosage form |
| 01/30/2013 | CN101772411B Use of a material based on a thermoplastic polymer having a high content of antioxidants for packaging dianhydrohexitols |
| 01/30/2013 | CN101721709B Calcium phosphate and amphiphilic polymer composite medicament-carrying nano-microsphere, preparation method and application |
| 01/30/2013 | CN101664392B Gentamycin sulfate tablets and preparation method thereof |
| 01/30/2013 | CN101590092B Traditional Chinese medicine combination for treating leukemia and preparation method thereof |
| 01/30/2013 | CN101559037B Binary solution type preparation for intravenous injection and intracerebral injection |
| 01/30/2013 | CN101518547B Ophthalmic preparation combination containing deproteinised calf blood extract |
| 01/30/2013 | CN101336978B Extraction method of total flavone of Hovenia dulcisThunb |
| 01/30/2013 | CN101272777B Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| 01/30/2013 | CN101229295B Bone regeneration pain-relieving plaster |
| 01/30/2013 | CN101087589B Solid pharmaceutical composition comprising valsartan |
| 01/30/2013 | CN101052383B Compositions and their uses for lysosomal enzyme deficiencies |
| 01/30/2013 | CN101039689B Topical compositions and methods for epithelial-related conditions |
| 01/29/2013 | US8362343 Nanotubes as mitochondrial uncouplers |
| 01/29/2013 | US8362231 RNA interference mediating small RNA molecules |
| 01/29/2013 | US8362085 Method for administering an NMDA receptor antagonist to a subject |
| 01/29/2013 | US8362062 Pharmaceutical compositions with improved dissolution |
| 01/29/2013 | US8361987 DNA vaccines encoding heat shock proteins |
| 01/29/2013 | US8361972 Pharmaceutical formulations containing an SGLT2 inhibitor |
| 01/29/2013 | US8361971 Tablet formulation of ezatiostat |
| 01/29/2013 | US8361539 Adding a water soluble drug into a solution, combining a curing agent and adding into an oil bath |
| 01/29/2013 | US8361515 Extracts of Chenopodium ambrosioides L., the compositions comprising said extracts, the preparing process and application thereof |
| 01/29/2013 | US8361514 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
| 01/29/2013 | US8361511 Tasteless nutritional supplement containing free amino acids |
| 01/29/2013 | US8361510 Nanogels for cellular delivery of therapeutics |
| 01/29/2013 | US8361509 Pharmaceutical dosage forms for the release of active compounds |
| 01/29/2013 | US8361508 Endothelial cell surface receptors |
| 01/29/2013 | US8361507 Eprosartan mesylate crystalline particles and a process for preparing pure eprosartan |
| 01/29/2013 | US8361506 Fast release dosage forms for antibiotics |
| 01/29/2013 | US8361505 Method and apparatus for producing a stable sub-colloidal nano-phase silver metal hydrosol |
| 01/29/2013 | US8361504 Materials and methods for wound treatment |
| 01/29/2013 | US8361503 useful as cell growth scaffolds; molded prior to implantation or administered to patient in an ungelled form prior to gelation where the composition gels in situ |
| 01/29/2013 | US8361502 Compositions and methods for the expansion and differentiation of stem cells |
| 01/29/2013 | US8361501 Non-adhesive elastic gelatin matrices |
| 01/29/2013 | US8361500 Tablet formulations containing 8-[{1-(3,5-Bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom |
| 01/29/2013 | US8361499 Controlled release hydrocodone formulations |
| 01/29/2013 | US8361498 Pharmaceutical formulation |
| 01/29/2013 | US8361497 Multi-phase, multi-compartment, capsular delivery apparatus and methods for using the same |
| 01/29/2013 | US8361496 Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 01/29/2013 | US8361494 Biomimetic iron-oxide-containing lipoprotein and related materials |
| 01/29/2013 | US8361492 Drug delivery system and methods of use |
| 01/29/2013 | US8361491 Mesoporous implants for administering substances and methods of producing implants |
| 01/29/2013 | US8361490 Biocompatible drug delivery apparatus and methods |
| 01/29/2013 | US8361489 Implantable devices for producing insulin |
| 01/29/2013 | US8361485 Conditioned cell culture medium compositions and methods of use |
| 01/29/2013 | US8361484 Polymer systems for lung volume reduction therapy |
| 01/29/2013 | US8361454 PVA particle for temporary embolic material and production process thereof, and temporary embolic material |
| 01/29/2013 | US8361444 Aerosolized fosfomycin/aminoglycoside combination for the treatment of bacterial respiratory infections |
| 01/29/2013 | US8361273 Polyurethane elastomers |
| 01/29/2013 | US8361272 Polyurethane elastomers |
| 01/29/2013 | US8361022 Apparatus for transdermal delivery of parathyroid hormone agents |
| 01/29/2013 | CA2676919C Novel biomaterials for ocular drug delivery and a method for making and using same |
| 01/29/2013 | CA2591581C Gel composition and methods |
| 01/29/2013 | CA2586807C Topical nepafenac formulations |
| 01/29/2013 | CA2582174C 4-hydroxy tamoxifen gel formulations |
| 01/29/2013 | CA2578015C Crystalline maltitol powder less prone to consolidation and method for production thereof |
| 01/29/2013 | CA2563556C Use of ciclesonide for the treatment of respiratory diseases in a smoking patient |
| 01/29/2013 | CA2545399C Protein-polysaccharide microcapsules for delivering active agents to the gi tract |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/29/2013 | CA2454050C Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 01/29/2013 | CA2450123C Biodegradable polyhydric alcohol esters |
| 01/29/2013 | CA2448665C Sustained-release analgesic compounds |
| 01/25/2013 | DE202007019476U1 Nicht-mucoadhäsive Filmdosisformen Non-mucoadhesive film dosage forms |
| 01/24/2013 | WO2013013172A1 Intravaginal devices for drug delivery |
| 01/24/2013 | WO2013013143A1 Fixed dose combination of bimatoprost and brimonidine |
| 01/24/2013 | WO2013013114A1 Bioavailable compositions of amorphous piperidinyl compounds |
| 01/24/2013 | WO2013013055A1 System for drug delivery and monitoring |
| 01/24/2013 | WO2013013038A2 Doping agents and polymeric compositions thereof for controlled drug delivery |
| 01/24/2013 | WO2013012954A2 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides |
| 01/24/2013 | WO2013012891A1 Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers |
| 01/24/2013 | WO2013012692A1 Pharmaceutical compositions comprising plant-based polysaccharides and uses thereof |
| 01/24/2013 | WO2013012662A2 Pharmaceutical compositions for rectal administration |
| 01/24/2013 | WO2013012628A2 Immune-stimulating photoactive hybrid nanoparticles |
| 01/24/2013 | WO2013012326A1 Tablet containing dehydroepiandrosterone (dhea) |
| 01/24/2013 | WO2013012307A1 Method for manufacturing a pharmaceutical composition in the form of extended-release tablets containing pirfenidone and use thereof in the regression of chronic renal insufficiency, breast capsular contracture and hepatic fibrosis in humans |
| 01/24/2013 | WO2013012199A1 Capsule formulation comprising montelukast and levocetirizine |
| 01/24/2013 | WO2013012022A1 Stable protein-containing preparation containing argininamide or analogous compound thereof |
| 01/24/2013 | WO2013012000A1 Water-based plaster |
| 01/24/2013 | WO2013011598A1 Liposome-containing preparation utilizing dissolution aid, and method for producing same |
| 01/24/2013 | WO2013011504A1 Materials and method for treating internal body cavities |
| 01/24/2013 | WO2013011501A1 Topical oily foam compositions |
| 01/24/2013 | WO2013011477A1 Pharmaceutical invention of tapentadol |
| 01/24/2013 | WO2013011438A1 Alginate tube drug delivery system and method therefor |
| 01/24/2013 | WO2013010956A1 Formulation of transparent and nutritive microemulsions |
| 01/24/2013 | WO2013010942A1 Composition and method for treating hpv |
| 01/24/2013 | WO2013010915A1 Intravaginal delivery system |
| 01/24/2013 | WO2013010737A1 Patch containing diclofenac and thiocolchicoside |
| 01/24/2013 | WO2013010489A1 Eucommia extract, preparation method therefor and use thereof |
| 01/24/2013 | WO2013010406A1 Rna body and the uses thereof |
| 01/24/2013 | WO2013010400A1 Compounds based on ibuprofen, preparation methods, uses and pharmaceutical preparation thereof |
| 01/24/2013 | WO2013010257A1 Microwave vacuum-drying of organic materials |